D uring my third week of high school chemistry, our instructor left in the middle of class in obvious pain and passed away shortly thereafter. This sad event could have spelled disaster for a budding career in chemistry, except for the fact that it occurred at
metals in biological systems and a respect for the power of kinetic studies to reveal chemical mechanism. The Vietnam War clouded every student's future in those days, so I had not thought much about graduate school. One day, Kidder asked me where I was going and said he thought Gunny ( Fig. 1 ) ran a good program at the University of Illinois. I called my father to talk it over and found that Gunny had been consulting at DuPont for years and had discovered my father's laboratory as comfortable place to sit and have coffee during nonstop visits. The topic of my graduate career had been raised in that arena as well, so it seemed as if fate had intervened. When Gunny convinced the Army to send a jet to pick up my (late) applications for graduate school and the reserve officer training core, I came to understand some important lessons about respect and power.
Immersion in Champaign, Gunny, and P450 cam
The first entry for "champaign" in the dictionary is "broad featureless plain," which is what I found after I left the Berkshires for the University of Illinois Urbana-Champaign campus. My experience there turned out to be the opposite of featureless; it was full of peaks and a few valleys. Gunny introduced me to a heme enzyme that he had discovered called P450 cam (CYP101). It was the first member of the bacterial branch of a family of mammalian enzymes being investigated by Minor J. Coon (University of Michigan), Ronald Estabrook (University of Texas Southwestern Medical Center), and a few others. The potential importance of mammalian P450 in xenobiotic and hormone metabolism was already clear, but the membrane association of these enzymes posed many potential problems. On the other hand, P450 cam is a soluble enzyme, so our efforts went toward developing purification strategies, identifying and characterizing the necessary accessory proteins, and ultimately crystallizing the enzyme. Thanks to his pioneering early studies that contributed to the discoveries of pyridoxal phosphate and lipoic acid by direct purification from kilograms of cells and tissues, Gunny believed in scale. So, as soon as we learned how to purify P450 cam , we scaled up to 300-liter fermentors and columns that were 1 foot in diameter and 6-feet tall. This gave us grams of enzyme with which to begin to dissect the P450 cam reaction cycle. Gunny had come from a background of microbiology and bacteriology, so his wholesale acceptance of biophysical methods to investigate mechanism was quite remarkable. In part, this derived from his willingness to allow us to explore any direction that we wished. Of course, it was substantially better for your emotional (and even physical) wellbeing if your initiatives proved successful! One successful approach during this period was our discovery of P450 cam reaction cycle intermediates, including the oxy intermediate, using stoppedflow kinetics (1) (2) (3) . Suddenly, the P450 problem expanded to a set of chemically distinct species, each with a role to play in catalysis. My first experience with Mössbauer spectroscopy, one of the methods used to characterize these intermediates, grew out of a friendship between Gunny and another renaissance man from the physics department, Hans Frauenfelder. The shared belief in the power of communication by these two scientists was so strong that they read each other's text books and then mandated joint group meetings. The first goal was to close the language gap by insisting that the first fifteen minutes of each presentation be designed to educate the other group in the language and concepts of the two fields. I learned a little bit about the physics of metals and spectroscopy in these sessions, but I learned a great deal about how physicists approach problems and how their findings could impact my understanding of biology. Mössbauer was new to enzymology in those days, but in collaboration with physicists Peter Debrunner and Eckard Münck (Fig. 1) , we learned how to load 57 Fe into P450 cam and obtain the first direct characterization of a heme enzyme viewed from the iron nucleus out (3, 4) . Many other adventures for a young student followed, including drives to Madison to obtain P450 cam EPR spectra with Helmut Beinert and William (Bill) OrmeJohnson, to Princeton to measure resonance Raman spectra with Thomas Spiro, to Chicago for electron nuclear double resonance studies with Brian Hoffman, and to New York for magnetic susceptibility studies with Thomas Moss (5, 6) . Each of these individuals was a pioneer in his technique, but more importantly, every one of them had the ability, indeed the absolute need, to see more in data than initially appeared on the chart paper. As a result, we learned as much about the characteristics of iron that make it ideal for oxygen activation and about how proteins can exploit this potential as we did about P450 cam .
The theme of collaboration between scientists with unique skills was brought home most clearly when Frauenfelder and Debrunner agreed to allow a young physics graduate student named Stephen Sligar ( Fig. 2) to set up shop in my lab space in the biochemistry department. His skills were the perfect complement to mine, so for the first time, we could build new instruments out of spare electronic parts and carry out computations to predict reaction outcomes. We found that an entirely new set of equipment was required for our new directions, which the National Institutes of Health was kind enough to fund. The outcome of this collaboration was a new understanding of how P450 cam , in particular, and oxygenases, in general, regulate the oxygen activation process. The beauty of a system that choreographs steps in O 2 activation by coupling together binding, redox, and structural energy reservoirs was inspiring to me and set a course that I maintained through the investigations of numerous systems throughout my career (7) (8) (9) .
Serendipity in science is a wonderful thing, and I will relate several stories to validate this opinion in this article. One fortuitous event occurred when an undergraduate who worked for me came in to complain that the brown P450 cam band on a big G-200 column had split into two parts. After some discussion, we found that he had forgotten to add mercaptoethanol to the buffer. Adding Cleland's reagent to the preparation collapsed the two brown bands into one, revealing the presence of a surface cysteine capable of cross-linking two P450s (10) . For some time, I had been trying to grow diffraction-quality crystals P450 cam without success. It turned out that the presence of a minor amount of the protein dimer was preventing crystallization. Once this was corrected, large crystals readily formed. The first x-ray diffraction studies were not successful, but alternative crystal forms grown from monomeric P450 cam resulted several years later in the first P450 crystal structure by Thomas Poulos (Fig. 2 ) in collaboration with Gunny (11).
Leaving Heme for Non-heme Iron
In 1974, the Army insisted that I leave Urbana and P450 for San Antonio, Texas. I had planned on two years of active duty, but soon after I arrived in Texas, the Vietnam War came to a close, and I was shifted to reserve status. Once again, I was unprepared for this shift in my career plan, so I scrambled to find a suitable postdoctoral opportunity. The perfect opportunity arose following a phone call to a former Illinois professor, John Wood, who had moved to Navarre, Minnesota, to be the first head of the new Gray Freshwater Biological Institute (an outgrowth of the Freshwater Society, which still exists to promote the preservation of our freshwater resources). Wood had received his training in England with Stanley Dagley, Gunny's long-term acquaintance and a current professor in the biochemistry department at the University of Minnesota. True to the Gunny/Dagley model for research by communication, Wood set up the Institute with one scientist from each of six disciplines. The result was two decades of progress with hundreds of collaborative publications and funding levels double the norm at the time. The physicist at the Institute was my collaborator from Illinois, Eckard Münck. Eckard's first hire was a young postdoctoral fellow from Richard Holm's group at Harvard University named Lawrence (Larry) Que, Jr. (Fig. 1) . Eckard, Larry, and I remain friends and active collaborators to the present day.
Working in the Institute just after it opened was a unique experience because its teak interior and 30-foot high window walls masked the fact that there was almost no scientific equipment inside. While the equipment base was being established, we had to find enzymes that we could study with a small fermentor, a French press, a centrifuge, and a Mössbauer instrument. This challenge ruled out P450 and permanently changed the direction of my research interests. Dagley and Wood had been instrumental in the discovery of non-heme, iron-containing, aromatic ring-cleaving dioxygenases, so we settled on protocatechuate 3,4-dioxygenase (3,4-PCD). The enzyme was purified from Pseudomonas aeruginosa (now reassigned as putida) by ammonium sulfate precipitation cuts and crystallization, so it fit well in the equipment-hungry institute. 3,4-PCD had been studied by Osamu Hayaishi and his students Hitoshi Fujisawa and Mitsuhiro Nozaki at Kyoto University in Japan. Consequently, we viewed it as a well understood system that we could purify easily to test the new Mössbauer instrumentation. It turned out that there was much to learn about 3,4-PCD and its mechanism. Over the years, we have returned time and time again to 3,4-PCD and related ring-cleaving dioxygenases to test new experimental techniques and to listen to what they could tell us about oxygen activation and the fundamental bases for enzyme function.
Just as P450 cam was the first purified heme enzyme to be probed by Mössbauer spectroscopy, 3,4-PCD provided some of the first Mössbauer data in the non-heme world (12) . In the mid-1970s, a single Mössbauer spectrum required 1 g of enzyme, and the spectra were printed out on a teletype machine. Nevertheless, a beautiful 6-line Mössbauer spectrum from the high-spin ferric ion in 3,4-PCD emerged. Addition of substrate and then O 2 produced spectra of intermediates in the reaction cycle. At the time, there was no EPR instrument in the state of Minnesota, so we drove periodically to Madison to work again with Bill Orme-Johnson. An interesting conundrum arose for the 3,4-PCD-substrate-O 2 complex in that the Möss-bauer and EPR spectra were incompatible. This is the type of challenge that Münck has used now for forty years to advance physics and biology together. It turned out that the zero-field splitting of the iron quantum states had inverted in the oxy complex, so the Mössbauer instrument saw the ground state while the EPR instrument saw an excited state (13) . Inverted zero-field splitting is now commonly recognized throughout metalloenzyme spectroscopy, but at the time, it was novel. A young spectroscopist named Edward Solomon (Stanford University) made a trip to Minnesota to discuss the new species and launched a collaboration that has lasted for more than thirty years. The Mössbauer spectra also showed that 3,4-PCD did not contain an iron-sulfur "rubredoxin-like" center, the only type of mononuclear iron site known at the time. Later, in some of the first applications of resonance Raman spectroscopy to non-heme enzymes, Larry Que (and independently Thomas Loehr of the Oregon Health & Science University) showed that the burgundy chromophore of 3,4-PCD was due to tyrosinate-to-Fe(III) charge transfer, confirming the novel type of metal center.
My experience with P450 cam had convinced me that the growth of enzyme crystals is a black art, and nothing has occurred in the years since to dissuade me from this opinion. Hayaishi had shown that 3,4-PCD readily forms brush-like crystals that allowed facile purification. We needed better formed crystals for crystallography. It turned out that the minor changes I had made in the purification and other undocumentable conditions at the Institute (crisp air, new vibration-free cold room, unused glassware) allowed diffraction-quality crystals that were over 3 mm long to grow overnight (Fig. 3) . Solution of the first x-ray crystal structure of a non-heme iron enzyme had to await two further breakthroughs. First, no amino acid sequence for a non-heme iron enzyme was known. This was solved for 3,4-PCD in collaboration with protein chemist James Howard (University of Minnesota), largely by brute force before the availability of amino acid sequencing instrumentation (14) . Second, the enormous asymmetric unit of the 3,4-PCD crystal prevented the solution of the phase problem for ten years until new approaches were developed. Then, my DuPont collaborator and now colleague at the University of Minnesota, Douglas (Doug) Ohlendorf, was able to apply the newly devised technique of using a locked rotation function in which the Patterson map was searched consistent with the observed non-crystallographic symmetry to solve the structure (15) . The structure showed that the active-site Fe(III) was bound by two histidine and two tyrosine ligands plus hydroxide to give an overall charge-neutral center. The clues to mechanism were there in front of us, but it took a few more years to put them together, as I will relate below.
New Department, New Direction in Extradiol Dioxygenases
In 1977, two years had passed since my arrival at the Institute, and although it was a difficult place to leave, it was time to move on. I had an offer from Earl Stadtman to come to his laboratory at the National Institutes of Health to pursue his new idea that what he termed "reactive oxygen species" were at the root of disease-causing DNA and protein damage. Looking back on it now, that would have been an excellent career choice! My choice instead was to move sixteen miles east to the campus of the University of Minnesota and a faculty position in the medical school's biochemistry department. Henricus (Harry) P. C. Hogenkamp had been hired to rebuild the department, and he was, and is, very difficult to turn down. He offered to pay my moving expenses and buy me an EPR instrument. That offer evolved to be twenty-five cents for bus fare and 90% of my start-up package for the instrument. Those initial shortcomings were repaid many times over in advice, encouragement, and support over the next two decades.
In my new lab at the university, I decided to build on the dioxygenase theme by exploring the second half of the catechol ring-cleaving family, the extradiol dioxygenases. Dagley and Wood had found and initially characterized 4,5-PCD, which seemed to be the perfect complement to 3,4-PCD. The problem with 4,5-PCD and other extradiol dioxygenases is that they are rather unstable and difficult to purify. However, I was encouraged by a bit of wisdom from Gunny that he delivered when I faced a similar problem purifying P450 cam reductase: "John, there are no unstable enzymes, just unstable biochemists." Eventually, we hit upon a stabilizing mixture of ferrous ammonium sulfate, cysteine, and glycerol that allowed 4,5-PCD to be purified and crystallized (16) . Had I known then what I know now about Fenton chemistry, I would not have tried this mixture; it comes back later in the story to alter my career once again. Mössbauer spectra of 4,5-PCD showed that it contained Fe(II) instead of the Fe(III) of 3,4-PCD, so the challenge of learning how both common iron oxidation states can activate O 2 was nicely set up. Later on, my students added three more previously uncharacterized Fe(II)-containing enzymes and published the first hypotheses for their mechanisms: Sanford Wolgel purified 2,3-PCD, which catalyzes extradiol cleavage of protocatechuate (PCA) on the opposite side of the vicinal catecholic hydroxyls than 4,5-PCD (17); Mark Harpel isolated gentisate 1,2-dioxygenase, in which the aromatic substrate hydroxyls are in para-rather than ortho-orientations (18) ; and Marcia Miller isolated homoprotocatechuate 2,3-dioxygenase (2,3-HPCD), which later was the vehicle for some of the most remarkable discoveries of my career (19) .
One-up on Heme: Non-heme Iron Uses Three Ligand Sites
In today's world, nitric oxide (NO) is widely recognized as a critical signaling molecule in mammalian metabolism, but in the early 1980s, it was only an extremely toxic gas. A report of the formation of an NO complex with Fe(II)-EDTA caught our attention because the complex had a chromophore and an intense EPR signal at g ϭ 4. The study of non-heme Fe(II)-containing enzymes was being frustrated by the lack of spectroscopic handles, and NO offered a potential solution. Gratifyingly, we found that adding NO anaerobically to 4,5-PCD (and later to all other non-heme Fe(II) enzymes we have tested) yielded a similar g ϭ 4 signal identified as arising from an S ϭ 3/2 ground state (16) . Graduate students David Arciero and Allen Orville used this new oxygen surrogate probe to make several observations that shaped our view of dioxygenase mechanisms (20, 21) . First, the affinity for NO in extradiol dioxygenases increased several orders of magnitude when substrate bound to the enzyme. This provided an explanation for the observation that extradiol dioxygenases do not bind O 2 in the absence of organic substrate despite the presence of Fe(II) in the active site. Second, labeling the two OH groups of PCA one at a time with 17 O (I ϭ 5/2) caused transferred hyperfine splitting in the EPR spectrum of the NO complex, showing that both catecholic hydroxyl groups and NO were bound at the same time to the iron. This observation suggested to us that one role of iron was to use three coordination sites to bind and organize the substrates for the reaction, a new con-cept for the role of biological metals. Under the assumption that NO and O 2 bind in the same metal coordination site, we proposed that electron density transferred from the organic substrate to the O 2 via the Fe(II) might give both substrates radical character, thereby allowing them to react directly with each other (Fig. 4) O-labeled substrate, hyperfine broadening showed that three iron coordination sites could be simultaneously occupied (23) . However, no evidence for actual reduction of the low-potential Fe(III) in resting or PCA-bound 3,4-PCD could be obtained in Mössbauer or optical studies (12) (13) 24) . This made direct binding of O 2 to the iron unlikely, and a novel mechanism for overcoming the triplet problem had to be sought. Larry Que and I proposed that the organic catechol is essentially "a poor man's flavin," such that O 2 initially attacks the substrate rather than binding to the iron (13, 25) . The triplet problem dictates that this would be a two-step process with a radical intermediate, but it would be facilitated by iron-induced ketonization of the substrate to localize a carbanion on the substrate ring. James Whittaker tested this by synthesizing pyridine N-oxide substrate analogs that spontaneously ketonize (26) . These molecules were superb inhibitors of 3,4-PCD. Moreover, their binding occurred in several steps, giving us our first insight into the complexity of substrate binding. Learning to monitor and quantify these steps brought stopped-flow kinetics back into our experimental repertoire with great impact on our future studies.
A Challenge from Hayaishi
There have been many singular events in my career that brought home the importance of mentorship and expectation. Early in our independent careers, Larry Que and I were invited to attend a pivotal meeting on oxygenase chemistry in Japan that featured the founders of the field: Gunny, Coon, Estabrook, Hayaishi, Konrad Bloch (Harvard University), Bo Malmström (Göteborg University, Göteborg, Sweden), Howard Mason (Oregon Health & Science University), Lars Ernster (Wenner-Gren Institute, Stockholm, Sweden), Vince Massey (University of Michigan), Jack Peisach (Albert Einstein College of Medicine), and many others (Fig. 5 ). We were clearly out of our depth. At one point, Hayaishi took us aside and told us that we were the future of non-heme oxygenase research. The only future I could see at the moment was surviving my talk in front of this audience the next day. However, I have used the challenge and the expectation ever since.
Slowly Finding Transient Intermediates in Dioxygenases
As I mentioned above, it is sometimes necessary to wait for scientific advances to provide the tools to explore important questions. In the case of 3,4-PCD, the first wait was for Doug Ohlendorf's crystal structure and subsequent exploration of substrate complexes by our joint student, Allen Orville (27) . Allen's structures demonstrated the substrate chelate-binding mode that we had predicted spectroscopically, but they also showed that substrate binds initially as a monodentate ion and then passes through an orchestrated series of shifts to eventually chelate and force one of the Tyr ligands and the hydroxide ligand off of the iron (28, 29) . The departing anions serve as active-site bases to deprotonate the incoming substrate; throughout the process, the iron site retains overall charge neutrality (29, 30) . The maintenance of overall charge at a metal center was proposed as a driving force for the reaction coordinate of metalloenzymes, a concept that has proven useful for other enzymes, as I will describe below. A second decade-long pause in the 3,4-PCD timeline was required for the development of density functional theory so that spectroscopic, structural, and kinetic findings could be related to mechanisms at a fundamental level. Our collaborator Edward Solomon had utilized both extra-and intradiol dioxygenases among other non-heme iron enzymes to develop novel magnetic circular dichroism and circular dichroism techniques to explore metal coordination geometries. After assigning all of the complex ligand-to-metal charge transfer bands that contribute to the optical spectrum of the 3,4-PCD-PCA complex, density functional theory computations provided a reasonable solution to the triplet problem (31) . It was proposed that O 2 binds to the Fe(III) and PCA in a concerted fashion. One electron from the reactive PCA orbital is donated to O 2 directly, but the second electron is transferred to the lowest energy d-orbital of the iron, which had been identified in the spectroscopic study. Simultaneously, another d-orbital electron of the opposite spin is given to the O 2 to complete the bonding process and to directly form the Fe(III)-alkylperoxo intermediate that will lead to the ring-open product in a similar manner to that illustrated in Fig. 4 for extradiol dioxygenases. In this way, the iron allows reaction of O 2 with the substrate in one step without a spin violation. Nature had solved the triplet problem in a new way, and there were more to come.
To make further progress in our mechanistic studies of dioxygenases, we knew that we needed to make enzyme variants, but determining a gene sequence and constructing an overexpression system were challenges at the time. My student Richard Frazee's sequence of the two 3,4-PCD genes and subsequent generation of the first intradiol dioxygenase mutants filled this gap, but it constituted his entire Ph.D. project (32, 33) . A few years later, technology caught up with the problem, so the cloning, overexpression, and mutagenesis of the extradiol dioxygenase 2,3-HPCD were complete in three weeks. The structure of the first extradiol dioxygenase solved by the Mitsui (Nagaoka University, Nagaoka, Japan), Eltis (University of British Columbia, Vancouver, Canada), and Bolin (Purdue University) groups in the mid-1990s was followed sometime later by Doug Ohlendorf's solution of the structure of our 2,3-HPCD (34 -36). Based on this structure, mutagenesis of several active-site second-sphere amino acids revealed new aspects of the mechanism but also demonstrated the remarkable ability of nature to tune electron distribution in a metalloenzyme active site. We found that 2,3-HPCD will turn over the alternative substrate 4-nitrocatechol (4-NC) at a small fraction of the rate observed for the native substrate, homoprotocatechuate (HPCA) (19) . Unlike HPCA, 4-NC has a visible spectrum, and the chromophore changes dramatically as the aromatic hydroxyls deprotonate or the ring is cleaved. Stopped-flow studies were used to reveal eight intermediates in the catalytic cycle of 2,3-HPCD as it bound and turned over 4-NC; these were the first intermediates detected for any extradiol dioxygenase (37) . My student Stephanie Groce showed that mutation of the active site's histidine 200 to any of several other amino acids greatly slowed the turnover of 4-NC and HPCA, so intermediates could potentially be trapped (38) . Finally, Michael Mbughuni used a newly developed rapid freeze quench (RFQ) device to trap intermediates from reaction of the variants with 4-NC and other substrates for EPR and Mössbauer studies (39, 40) . Similar studies revealed the role of tyrosine 257 in distorting the aromatic ring of the substrate to promote electron transfer to the O 2 (41, 42) . The studies showed that our original idea of an electron moving from the aromatic substrate to the O 2 via the iron was valid, but also that the enzyme could exert exquisite control over the process. We found cases in which 1) one electron moves from the Fe(II) to the O 2 (the first non-heme iron-superoxo intermediate), 2) electrons from both the substrate and Fe(II) move to the O 2 to make a substrate radical-Fe(III)-peroxo complex, and (3) an alkylperoxo complex that forms without any net change in iron oxidation state. We described this as a "shell game for electrons," wherein all locations within the substrate-Fe-O 2 pathway for the mobile electrons are possible, but in the native reaction, the enzyme optimizes the formation of the substrate and oxygen radical pair for rapid and specific recombination (43) .
Intermediates in Crystals: Search Long Enough, and They Will Find You
There is one more dioxygenase story involving crystals and serendipity that illustrates the power of simply getting out of the way of creative students. Postdoctoral fellow Elena Kovaleva joined the lab with a solid background in enzymology and kinetics, so I expected her to continue on that track. Instead, she decided to launch a new career in crystallography. My laboratory had enjoyed many collaborations with strong crystallographers, but it was hardly the place to learn crystallography. Nevertheless, with help from crystallographer Carrie Wilmot at the University of Minnesota, Elena rapidly gained the essential computational skills and showed that she had the green thumbs needed to grow excellent crystals. Her crystals of 2,3-HPCD diffracted to much higher resolution than our past crystals, and they contained all four subunits of the homodimeric enzyme in the asymmetric unit. This gave us four independent views of the active site. Remarkably, after soaking the crystals in 4-NC substrate and exposing them to the near-zero residual O 2 in an anaerobic crystal-growing chamber, three oxygenated intermediates of the reaction cycle were trapped at high occupancy in different active sites within the asymmetric unit (44) . These were the key substrate radical-Fe(II)-superoxo, Fe(II)-alkylperoxo, and Fe(II)-bound product intermediates (Fig. 6) . They gave us the first structural verification of the mechanism we first proposed nearly three decades earlier (21) . There are very few days like this in the laboratory! In the time since this breakthrough, the ability of enzyme crystals to virtually stop reactions at multiple points in the reaction cycle has been observed using crystals of other enzymes by our laboratory and others, suggesting that this will be a generally useful approach going forward (41, (45) (46) (47) .
Doubling Down on Iron with Methane Monooxygenase
If we go back in time twenty years before the magic crystals of 2,3-HPCD, we find another branch point in my career driven by a unique student. Several years after my departure from the Gray Freshwater Biological Institute, the headship passed to Richard S. Hanson (now professor emeritus at the University of Minnesota), an expert microbiologist who studied methanotrophic bacteria. Methanotrophs grow only using methane as a source of carbon and energy, and the enzyme that makes this possible is methane monooxygenase (MMO). Years of work by Howard Dalton at the University of Warwick in the United Kingdom had shown that the soluble form of the MMO hydroxylase (MMOH) component contains iron and catalyzes the same enormous range of reactions as P450. I was naturally attracted to the study of MMO, but all of the attempts by others to purify it had resulted in very low specific activity and protein yields. At the time, Hanson, Münck, and others at the Institute ran a summer school for graduate students, and one of these was Brian Fox. In discussions with Hanson, Fox became interested in MMO and came to my laboratory as a graduate student the following year to find methods to isolate and study its mechanism. No progress was made for some time, until one day Fox looked across the bench at students purifying extradiol dioxygenases using the ferrous ammonium sulfate/cysteine/glycerol-stabilizing concoction described above. Of course, this completely stabilized MMOH, resulting in purification to homogeneity with no loss in activity and yields on the gram scale from the native host (48) .
Working with fellow students Wayne Froland and David Jollie, Fox purified the MMO reductase and regulatory B (MMOB) component and then demonstrated that chemically reduced MMOH with MMOB present could produce methanol in high yield during a single turnover (48) . Mössbauer and EPR data showed that MMOH contained a dinuclear iron cluster like that found in ribonucleotide reductase and that the O 2 -reactive form was reduced by two electrons relative to the resting state (49) . Accordingly, Kristoffer Andersson showed that hydrogen peroxide could replace both O 2 and the two electrons to allow product-forming continuous turnover by a peroxide shunt similar to that known for P450 (50) . Another connection to P450 was made by Froland working with Heinz Floss (University of Washington) to synthesize chiral car- (51) . This molecule was converted to ethanol by MMO without loss of tritium and then chemically derivatized for analysis. Tritium NMR showed that 35% of the chirality of the molecule was lost during ethanol formation, implying that the reaction occurs by hydrogen atom abstraction and very rapid rebound, just as John Groves at Princeton University and others had proposed for P450.
The Day "Q" Found Q One day, I suggested to my student Sang-Kyu Lee that he use Fox's single-turnover system to look for intermediates in the MMOH reaction cycle. Our hopes for success were not high because all of the states of MMOH that we knew of then were EPR-silent and nearly colorless. One exception to this was the diferrous reactive state that exhibited EPR signal at g ϭ 16 from an integer spin state that Fox had noticed and that postdoctoral fellow Michael Hendrich, currently at Carnegie Mellon University, had theoretically and computationally described (52) . Using RFQ, Lee showed that the g ϭ 16 signal rapidly disappeared upon reaction with O 2 and that the rate of this process was independent of the presence of methane. He also found that on a longer time scale than the g ϭ 16 signal decay, the reaction solution briefly turned intensely yellow. The rate of formation of the yellow intermediate was independent of substrate concentration, but the rate of its decay exhibited a linearly dependence. We called Lee "Q" for short in the lab, so the new yellow species became compound Q. The mismatch of rate constants in the reactions leading up to Q suggested an undetected intermediate between the initial O 2 complex (O) with diferrous MMOH and Q. Based on electron stoichiometry, this species would be a peroxo intermediate (P). The chiral ethane experiment suggested a radical intermediate (R) after Q. Thus, it seemed like fate that someone named Q would make this discovery in my laboratory. Lee was also able to trap the product complex using a chromophoric alternative substrate and monitor its decay to the resting enzyme. Thus, in one JBC publication, we were able to describe each step in the entire reaction cycle of MMOH (Fig. 7) (53). Intermediate Q lives more than one second in the absence of substrate, and thus, it could be trapped by RFQ. Mössbauer spectra of Q revealed that both irons of the diiron cluster were in the Fe(IV) oxidation state, a species that was unique in both biology and chemistry (54) . Nature had created a special reagent to break the ultimately stable bond of methane (55) . Later, Mössbauer and extended x-ray absorption fine structure studies with Eckard Münck (now at Carnegie Mellon University) and Larry Que (now back at Minnesota) showed that the cluster in Q assumed a diamond core shape with bis--oxo bridging of the two Fe(IV) ions (Fig. 7) (56) .
Monitoring Reactions of Activated Oxygen in Real Time
The ability to monitor the discrete step in which compound Q directly reacts with substrates opened new avenues in oxygenase research. For the first time, it became a relatively straightforward task to monitor the kinetics of oxygen transfer to substrates, determine thermodynamic and activation parameters, and measure kinetic isotope effects (KIE) for the core oxygenase reaction step rather than having to extract these types of data from steady-state measurements or multistep reactions. My student Jeremy Nesheim (now deceased) monitored the Q reaction with deuterated methane and found a decidedly nonclassical KIE value of 50 (57) . This large value supported the proposal of a P450-like hydrogen atom abstraction mechanism but also suggested that the reaction occurred with a substantial quantum tunneling component. Curiously, none of the alternative MMO substrates (including ethane) exhibited a deuterium KIE when reacting with Q. To solve this puzzle, we had to first understand the role of MMOB.
Early on, we had shown that MMOB binds to the MMOH ␣-subunit and changes many physical and kinetic properties, including a radical change in the regiospecificity of hydroxylation of complex alternative substrates and a 1000-fold increase in the reaction rate with O 2 (58 -60) . We began to understand the origin of these dramatic changes after my student Bradley Wallar solved the structure of MMOB by NMR approaches in collaboration with Kevin Mayo and his student Shou-Lin Chang at the University of Minnesota (61) . The technique also identified specific MMOB residues that contact the MMOH surface as the regulatory protein-protein complex forms (62) . One of the most remarkable results I have witnessed followed when these MMOB residues were mutated in five different areas of the protein. Each set of mutations caused a dramatic change in the rate constant for a different step in the single-turnover reaction cycle of MMOH (63) . One of the mutations caused the rate of reaction of Q with larger substrates to greatly accelerate. Years before, we had solved the crystal structure of MMOH from Methylosinus trichosporium in collaboration with Doug Ohlendorf (64) following on the elegant studies of the Methylococcus capsulatus MMOH structure by the Lippard group at the Massachusetts Institute of Technology (65) . Both structures showed that the diiron cluster is completely buried inside the protein with no obvious access channel to the surface. Based on the new insight from the MMOB mutant, we proposed that the role of MMOB was to open a channel into the diiron cluster the size of methane and, in this way, act as a molecular sieve to select methane from all of the other potential substrates that could be oxidized by Q (63, 66) . The MMOB mutation apparently increased the size of the sieve. This idea was tested in two ways. First, Brian Brazeau showed that the Arrhenius plot for Q reaction with methane exhibits a concentration-dependent break, suggesting a change from rate-limiting substrate binding to rate-limiting C-H bond cleavage in the observable temperature range (67) . Plots for substrates larger than methane exhibited no break, and the reactions were always limited by binding, thereby accounting for the lack of an observed KIE. Second, the ability to accelerate the reaction of larger substrates using the MMOB mutant suggested an interesting experiment. If the acceleration was sufficient, C-H bond breaking would become ratelimiting, and a KIE would be observed. This induction of a KIE was observed for ethane, although the KIE remained in the classical range (68) . Thus, nature apparently learned to select methane in a bacterium that can grow only on this one substrate by constructing a molecular sieve with the appropriate pore size and then accelerating the reaction specifically for methane by using quantum tunneling. I would like to claim that I predicted this result, but in fact, I had to learn it from the enzyme (69) .
In recent years, students Jingyan Zhang, Hui Zheng, and Rahul Banerjee have used the MMOB mutants to selectively slow the decay of specific MMOH reaction cycle steps so that new intermediates could be trapped (69 -71).
The system has now given us insight into eight discrete intermediates in the O 2 activation sequence. All of the intermediates in the reaction cycles of MMOH accommodate our rule of thumb by maintaining a constant net charge. These intermediates and the manner in which they evolve from one another have been very useful for the identification and characterization of intermediates in other non-heme iron oxygenase systems, which have mushroomed in number and diversity over the past forty years (72) .
One Ligand Set, Many Mechanisms
One prevalent metal-binding mode that emerged from the extradiol ring-cleaving dioxygenase structures was termed the 2-His-1-carboxylate facial triad (2H1C) by Larry Que (73) . The two histidine and one aspartate or glutamate ligands that occupy one face of the iron coordination leave the other side open to simultaneously bind substrate and O 2 , as we showed first in the early spectroscopic studies described above (20, 21) . The superfamily has now grown to at least nineteen subfamilies, many of which begin catalysis in a manner analogous to that which we described for the extradiol dioxygenases. These enzymes first generate a substrate-assisted iron-superoxo intermediate but then diverge to carry out a broad range of chemistries (45) . In some cases, Asp/Glu is replaced by a third histidine, but the mechanism remains similar. We have studied many of these 2H1C enzymes over the years in studies that I have not had space to describe here. These include Allen Orville's study of isopenicillin N-synthetase (74) , Amy Rocklin's study of 1-aminocyclopropane-1-carboxylic acid oxidase (75) ; Aimin Liu's study of (S)-2-hydroxypropylphosphonic acid epoxidase (76) ; and a twodecade-long study of Rieske dioxygenases initiated by students Matt Wolfe, Daniel Altier, Matt Neibergall, and Sarmistha Chakrabarty and being carried on by Brent Rivard and Melanie Rogers (72, (77) (78) (79) . All of these studies started with a collaboration with another laboratory that complemented our interests and techniques. Each study brought to light a new and unexpected strategy for the iron center to bind substrate and activate O 2 . Importantly, each study also revealed a new approach for regulation of the reaction to prevent adventitious chemistry and release of reactive oxygen species.
An Annotator's Gift: A New Role for the Diiron Cluster
One type of 2H1C Fe(II) enzyme that we have not studied is linked to ␣-ketoglutarate (␣-KG) for initial oxygen activation. Our one attempt to pursue this type of enzyme REFLECTIONS: Life in a Sea of Oxygen led us in a completely different direction. Elegant studies in many laboratories, but particularly that of Christopher Walsh at Harvard University, have shown that natural product antibiotics are often biosynthesized on nonribosomal peptide synthetases (NRPS) (80) . One of the simplest NRPS-based pathways leads to the biosynthesis of chloramphenicol. Annotation of the gene cluster for this pathway identified a probable ␤-hydroxylase as an ␣-KGlinked oxygenase. My postdoctoral fellow Thomas Makris, currently at University of South Carolina, set out to isolate this enzyme for us, but he rapidly discovered that, despite his efforts, we still lacked an ␣-KG oxygenase for study. The enzyme he found, CmlA, does catalyze ␤-hydroxylation, but it does so with a diiron cluster as found in MMOH (81) . This is the first diiron oxygenase to catalyze ␤-hydroxylation and the first to function in an NRPS biosynthetic pathway. The initial misidentification arose from the fact that the sequence of CmlA does not correlate with the usual four-helix bundle structure of known diiron oxygenases like MMO. Instead, the sequence suggested a metallo-␤-lactamase fold, which is not known to bind diiron clusters for O 2 activation. My student Cory Knoot recently solved the crystal structure of CmlA in collaboration with Carrie Wilmot and confirmed the lactamase fold (82) . The structure suggested that CmlA is regulated by a unique "foot pedal switch," wherein a local conformational change caused by CmlA sitting down on the NRPS loaded covalently with the substrate causes a glutamate to swing in and ligate the diiron cluster. In turn, this allows O 2 to bind and become activated, presumably by shifting the redox potential of the cluster. To date, we have identified fifty additional enzymes similar to CmlA involved in the biosynthesis of antibiotic, chemotherapy, and biostatic drugs. Based on this experience, it occurred to me that errors in sequence data base annotation may provide a rich source for discovery.
Learning from Oxygenases
In many ways, the study of oxygenases and related oxidases is an investigation into how we survive living every day in a sea of oxygen. It is in equal parts a study of activation chemistry and of regulatory strategies. Remarkable diversity in both of these aspects of catalysis has come to light during the time I have studied oxygenases. One need only review the iron oxidation states of the enzymes discussed here at the stage of oxygen transfer to substrates to appreciate this diversity: substrate radical-Fe(II)-O 2 . for extradiol dioxygenases; Fe(III)-alkylperoxo for intradiol dioxygenase; Fe(IV)ϭO for ␣-KG oxygenases or isopenicillin N-synthase; bis--oxo-diFe(IV) or the electronic equivalent heme radical-Fe(IV)ϭO for MMO and P450, respectively; and finally, a potential Fe(V)-oxo-hydroxo for Rieske dioxygenases. Similarly, regulation is dictated by variations on the themes of substrate-triggered O 2 binding in the ring-cleaving dioxygenases and CmlA, cluster sequestration and MMOB binding in MMO, and remote Rieske cluster reduction in the Rieske dioxygenases. None of these essential contributions to catalysis was anticipated, but each was enlightening. I have taken great pleasure in being part of the origin and growth of the field of bioinorganic chemistry, the study of metals in biology. It is a discipline that grew up almost simultaneously and synergistically in Europe, North America, Asia, and Australia, and from these roots, it has evolved into strong societies on each continent. It is truly an international field that has brought me collaborators and friends from all parts of the globe. Finally, it has been the greatest honor of my life to encourage the individual students named here and many more who have worked in my laboratory as they learned to listen to the stories that the oxygenase enzymes have to tell.
